NewsBenzingaRBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $290 RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $290 Benzinga 2026.10.06 13:15 (GMT+0) Open on Benzinga Other news EVgo Q2 2026 Earnings Call: Complete Transcript Geron Q2 2026 Earnings Call: Complete Transcript NCR Voyix Q2 2026 Earnings Call Transcript Lifecore Biomedical Q2 2026 Earnings Call Transcript HTX Lists AKAM, VKTX, H100, FOXA, INTU, CT Perpetual Contracts Full Transcript: Teleflex Q2 2026 Earnings Call
